Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
47 hedge funds and large institutions have $58.1M invested in Alpine Immune Sciences Inc in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 13 closing their positions.
5% more capital invested
Capital invested by funds: $55.4M → $58.1M (+$2.69M)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
19% less funds holding
Funds holding: 58 → 47 (-11)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.68M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$1.27M |
| 3 |
Axa
Paris,
France
|
+$620K |
| 4 |
AC
Ascend Capital
Orinda,
California
|
+$444K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.56M |
| 2 |
JP Morgan Chase
New York
|
-$1.28M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$968K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$470K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$417K |
ALPN Hedge Fund Activity: Q2 2016 in Review
47 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2016, worth a combined $58.1M — up 4.9% from $55.4M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ALPN and 3 opened new positions — a net loss of 10 holders — while 16 trimmed existing stakes and 15 added.
The largest buyer was BVF Inc, adding an estimated $1.68M. The largest seller was RA Capital Management, exiting entirely with an estimated $2.56M sold.
- 47 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2016, down from 58 in Q1 2016.
- Funds reported $58.1M of Alpine Immune Sciences Inc stock for Q2 2016, up 4.9% quarter-over-quarter.
- 3 funds opened new Alpine Immune Sciences Inc positions in Q2 2016 and 13 closed out, a net change of -10 holders.
- The largest Alpine Immune Sciences Inc buyer in Q2 2016 was BVF Inc, an estimated $1.68M added.
- The largest Alpine Immune Sciences Inc seller in Q2 2016 was RA Capital Management, an estimated $2.56M sold.
Based on aggregated 13F filings for Q2 2016.